Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
322.14
-3.16 (-0.97%)
Jul 27, 2026, 2:32 PM EDT - Market open
PRAX Market Cap
PRAX has a market cap or net worth of $8.98 billion as of July 27, 2026. Its market cap has increased by 644.53% in one year.
Market Cap
8.98B
Enterprise Value
7.48B
1-Year Change
644.53%
Ranking
Category
Stock Price
$322.14
ChartMarket Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.98B, an increase of 1,186.62%. That is a compound annual growth rate of 55.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 8.98B | 21.85% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 10.24B |
| Apogee Therapeutics | 10.08B |
| Krystal Biotech | 9.88B |
| Halozyme Therapeutics | 9.72B |
| Ionis Pharmaceuticals | 9.35B |
| Kymera Therapeutics | 9.10B |
| Spyre Therapeutics | 8.98B |
| Crinetics Pharmaceuticals | 8.83B |